<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Antifibrotic Therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/antifibrotic-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 05 Jan 2026 20:29:54 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Antifibrotic Therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Pirfenidone’s Promise for Ovarian Endometriosis Treatment</title>
		<link>https://bioengineer.org/pirfenidones-promise-for-ovarian-endometriosis-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 20:29:29 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antifibrotic Therapy]]></category>
		<category><![CDATA[Antifibrotik Tedavi]]></category>
		<category><![CDATA[Fare Modeli** * **Pirfenidon:** Çalışmanın ana konusu ve araştırılan ilaç. * **Ovarian Endometriozis:** Araştırmanın odaklandığı endometriozis]]></category>
		<category><![CDATA[Fibrosis]]></category>
		<category><![CDATA[Fibrozis]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Pirfenidon]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **Pirfenidone]]></category>
		<category><![CDATA[Mouse Model** **Açıklama:** 1. **Pirfenidone:** Çalışmanın ana odağı olan ilaç. 2. **Ovarian Endometriosis:** Araştırmanın spesifik olarak hedef aldığı endometriozis formu (]]></category>
		<category><![CDATA[Ovarian Endometriosis]]></category>
		<category><![CDATA[Ovarian Endometriozis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/pirfenidones-promise-for-ovarian-endometriosis-treatment/</guid>

					<description><![CDATA[Recent research has brought forth significant insights into the complex interplay between fibrosis and ovarian function, particularly within the context of endometriosis. Endometriosis, a condition characterized by the abnormal growth of endometrial tissue outside the uterus, has long puzzled researchers due to its multifaceted nature and various manifestations. The contribution of fibrosis—a pathological process that [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313859</post-id>	</item>
	</channel>
</rss>
